H.-U. Meier-Kriesche

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

Kenneth Lamb, Sundus A. Lodhi, H.-U. Meier-Kriesche · American Journal of Transplantation · 2010 · 901 citations

Urology, Transplantation, Critical Reappraisal +8

Immunosuppression: Evolution in Practice and Trends, 1994–2004

H.-U. Meier-Kriesche, S. Li, Rainer W.G. Gruessner et al. · American Journal of Transplantation · 2006 · 557 citations · Full text

Immunosuppressive Therapy, Immunology, Autoimmunity +5

Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial

Robert S. Gaston, Bruce Kaplan, T. Shah et al. · American Journal of Transplantation · 2009 · 187 citations · Full text

Molecular Pharmacology, Controlled-dose Mycophenolate Mofetil, Therapeutic Drug Monitoring +8

Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study

Antoine Dürrbach, José Medina‐Pestana, Sander Florman et al. · American Journal of Transplantation · 2016 · 152 citations · Full text

Associations Between EBV Serostatus and Organ Transplant Type in PTLD Risk: An Analysis of the SRTR National Registry Data in the United States

Vikas R. Dharnidharka, Kenneth Lamb, Jon A. Gregg et al. · American Journal of Transplantation · 2012 · 128 citations · Full text

Ptld Risk, Transplantation, Medicine +8